Capital Directions Investment Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Capital Directions Investment Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-103	Closed	-$38K	–	255
2022 Q2	$38K	Buy	103 +98	+1,960%	+$236	0.01%	142
2022 Q1	$79K	Buy	+5	New	+$55	0.02%	114
2021 Q4	–	Sell	-1	Closed	-$13K	–	252
2021 Q3	$13K	Hold	1	–	–	﹤0.01%	226
2021 Q2	$13K	Buy	+1	New	+$32	﹤0.01%	201
2021 Q1	–	Sell	-1	Closed	-$12K	–	372
2020 Q4	$12K	Hold	1	–	–	﹤0.01%	176
2020 Q3	$11K	Hold	1	–	–	﹤0.01%	183
2020 Q2	$10K	Hold	1	–	–	﹤0.01%	190
2020 Q1	$7K	Hold	1	–	–	﹤0.01%	214
2019 Q4	$8K	Buy	+1	New	+$62	﹤0.01%	225

Capital Directions Investment Advisors's ZSAN Position: Q3 2022 in Review

Capital Directions Investment Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q3 2022, closing a stake of 103 shares — an estimated $38K sold.

Capital Directions Investment Advisors first reported a position in ZSAN in Q4 2019 and held it in 9 quarters. The position peaked at $79K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZSAN as of Q3 2022.

Capital Directions Investment Advisors reported no remaining Zosano Pharma Corporation position as of Q3 2022 after selling out during the quarter.
Capital Directions Investment Advisors sold 103 Zosano Pharma Corporation shares in Q3 2022, an estimated $38K.
Capital Directions Investment Advisors first reported a position in Zosano Pharma Corporation in Q4 2019 and held it in 9 quarters.
Capital Directions Investment Advisors's Zosano Pharma Corporation position peaked at $79K in Q1 2022.
1 fund tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2022.

Based on Capital Directions Investment Advisors's 13F filing for Q3 2022, filed 2 Nov 2022.